Preparation and Characterization of Self-Microemulsifying Drug Delivery System of Olmesartan Medoxomil for Bioavailability Improvement
Open Access
- 24 September 2012
- journal article
- research article
- Published by Wiley in Journal of Pharmaceutics
- Vol. 2013, 1-9
Abstract
Olmesartan medoxomil (OLM) is an angiotensin II receptor blocker (ARB) antihypertensive agent administered orally that has absolute bioavailability of only 26% due to the poor aqueous solubility (7.75 μg/ml). The aim of the present investigation was to develop a self-microemulsifying drug delivery system (SMEDDS) to enhance the oral absorption of OLM. The solubility of OLM in various oils, surfactants, and cosurfactants was determined. Pseudoternary phase diagrams were constructed using Acrysol EL 135, Tween 80, Transcutol P, and distilled water to identify the efficient self-microemulsification region. Prepared SMEDDS was further evaluated for its emulsification time, drug content, optical clarity, droplet size, zeta potential, in vitro dissolution, and in vitro and ex vivo drug diffusion study. The optimized formulation S2 contained OLM (20 mg), Tween 80 (33%v/v), Transcutol P (33%v/v), and Acrysol EL 135 (34%v/v) had shown the smallest particle size, maximum solubility, less emulsification time, good optical clarity, and in vitro release. The in vitro and ex vivo diffusion rate of the drug from the SMEDDS was significantly higher than that of the plain drug suspension. It was concluded that SMEDDS would be a promising drug delivery system for poorly water-soluble drugs by the oral route.Keywords
This publication has 23 references indexed in Scilit:
- Formulation and development of a self-nanoemulsifying drug delivery system of irbesartanJournal of Advanced Pharmaceutical Technology & Research, 2011
- Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancementJournal of Pharmacy and Bioallied Sciences, 2011
- Enhanced oral bioavailability of dexibuprofen by a novel solid Self-emulsifying drug delivery system (SEDDS)European Journal of Pharmaceutics and Biopharmaceutics, 2009
- Nanoemulsion Components Screening and Selection: a Technical NoteAAPS PharmSciTech, 2009
- Exemestane Loaded Self-Microemulsifying Drug Delivery System (SMEDDS): Development and OptimizationAAPS PharmSciTech, 2008
- Preparation and evaluation of self-microemulsifying drug delivery system of oridoninInternational Journal of Pharmaceutics, 2008
- Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspectiveAdvanced Drug Delivery Reviews, 2008
- Preparation and In Vitro Evaluation of Self-Microemulsifying Drug Delivery Systems Containing IdebenoneDrug Development and Industrial Pharmacy, 2000
- Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrineInternational Journal of Pharmaceutics, 1998
- Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugsInternational Journal of Pharmaceutics, 1994